İçeriğe geç
akaturk Akademik ölçüm
Giriş yap Kayıt ol

OpenAlex konusu

Inflammatory Biomarkers in Disease Prognosis

Bu sayfa OpenAlex konu etiketine göre çalışmaları ve o konuda görünen akademisyenleri listeler. YÖKSİS temel alan / yan dal değildir.

OpenAlex 12.592 eser 415 yazar konusu

Çalışmalar

12.592 eser

  1. Paraneoplastic Thrombocytosis in Ovarian Cancer 2012
    YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %1 OpenAlex 99.7%

    BACKGROUND: The mechanisms of paraneoplastic thrombocytosis in ovarian cancer and the role that platelets play in abetting cancer growth are unclear. METHODS: We analyzed clinical data on 619 patients with epithelial ovarian cancer to test associations between platelet counts and disease outcome. Human samples and mou…

  2. Pembrolizumab or Placebo Plus Etoposide and Platinum as First-Line Therapy for Extensive-Stage Small-Cell Lung Cancer: Randomized, Double-Blind, Phase III KEYNOTE-604 Study 2020
    OpenAlex üst %1 OpenAlex 99.8%

    PURPOSE Pembrolizumab monotherapy has shown antitumor activity in patients with small-cell lung cancer (SCLC). The randomized, double-blind, phase III KEYNOTE-604 study compared pembrolizumab plus etoposide and platinum (EP) with placebo plus EP for patients with previously untreated extensive-stage (ES) SCLC. METHODS…

  3. Factors that influence collection and engraftment of autologous peripheral-blood stem cells. 1995
    YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %1 OpenAlex 99.2%

    PURPOSE: To analyze factors that affect the collection of peripheral-blood stem cells (PBSC) before transplant and the tempo of engraftment after transplant. PATIENTS AND METHODS: A consecutive series of 243 patients with breast cancer (n = 87), malignant lymphoma (n = 90), multiple myeloma (n = 32), or other malignan…

  4. Factors that influence collection and engraftment of autologous peripheral-blood stem cells. 1995
    YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %1 OpenAlex 99.2%

    PURPOSE: To analyze factors that affect the collection of peripheral-blood stem cells (PBSC) before transplant and the tempo of engraftment after transplant. PATIENTS AND METHODS: A consecutive series of 243 patients with breast cancer (n = 87), malignant lymphoma (n = 90), multiple myeloma (n = 32), or other malignan…

  5. Mean platelet volume (MPV) as an inflammatory marker in ankylosing spondylitis and rheumatoid arthritis 2008
    YÖKSİS SJR Q2 JCR Q3 OpenAlex üst %10 OpenAlex 94.5%

    Özet henüz yok.

  6. Mean platelet volume (MPV) as an inflammatory marker in ankylosing spondylitis and rheumatoid arthritis 2008
    YÖKSİS SJR Q2 JCR Q3 OpenAlex üst %10 OpenAlex 94.5%

    Özet henüz yok.

  7. Mean platelet volume MPV as an inflammatory marker in ankylosing spondylitis and rheumatoid arthritis 2008
    YÖKSİS SJR Q2 JCR Q3 OpenAlex üst %10 OpenAlex 94.5%

    Özet henüz yok.

  8. Mean platelet volume MPV as an inflammatory marker in ankylosing spondylitis and rheumatoid arthritis 2008
    YÖKSİS SJR Q2 JCR Q3 OpenAlex üst %10 OpenAlex 94.5%

    Özet henüz yok.

  9. The Activated Stroma Index Is a Novel and Independent Prognostic Marker in Pancreatic Ductal Adenocarcinoma 2008
    OpenAlex üst %10 OpenAlex 92.0%

    Özet henüz yok.

  10. Mean platelet volume MPV as an inflammatory marker in ankylosing spondylitis and rheumatoid arthritis 2008
    YÖKSİS SJR Q2 JCR Q3 OpenAlex üst %10 OpenAlex 94.3%

    Özet henüz yok.

  11. Mean platelet volume (MPV) as an inflammatory marker in ankylosing spondylitis and rheumatoid arthritis 2008
    YÖKSİS SJR Q2 JCR Q3 OpenAlex üst %10 OpenAlex 94.3%

    Özet henüz yok.

  12. Mean platelet volume (MPV) as an inflammatory marker in ankylosing spondylitis and rheumatoid arthritis 2008
    YÖKSİS SJR Q2 JCR Q3 OpenAlex üst %10 OpenAlex 94.3%

    Özet henüz yok.

Akademisyenler

415 akademisyen